Brief: IGC Pharma Receives Notice Of Allowance For Patent On Seizures
June 6 (Reuters) - IGC Pharma Inc IGC.A :
* IGC PHARMA RECEIVES NOTICE OF ALLOWANCE FOR PATENT ON
SEIZURES
* IGC PHARMA, INC.-RECEIVED NOTICE OF ALLOWANCE FROM
COMMISSIONER
OF PATENTS, CANADA, FOR PATENT FILING ON USE OF CANNABINOIDS IN
TREATMENT OF SEIZURES
Source text for Eikon: ID:nBw7BSd92a
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment